BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4096721)

  • 1. Myoadenylate deaminase deficiency and malignant hyperthermia susceptibility: is there a relationship?
    Fishbein WN; Muldoon SM; Deuster PA; Armbrustmacher VW
    Biochem Med; 1985 Dec; 34(3):344-54. PubMed ID: 4096721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoadenylate deaminase deficiency: inherited and acquired forms.
    Fishbein WN
    Biochem Med; 1985 Apr; 33(2):158-69. PubMed ID: 4004819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of adenylate deaminase, adenylate kinase, and creatine kinase in frozen human muscle biopsy specimens relative to type 1/type 2 fiber distribution: evidence for a carrier state of myoadenylate deaminase deficiency.
    Fishbein WN; Armbrustmacher VW; Griffin JL; Davis JI; Foster WD
    Ann Neurol; 1984 Mar; 15(3):271-7. PubMed ID: 6326659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoadenylate deaminase deficiency: a new disease of muscle.
    Fishbein WN; Armbrustmacher VW; Griffin JL
    Science; 1978 May; 200(4341):545-8. PubMed ID: 644316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoadenylate deaminase deficiency: primary and secondary types.
    Fishbein WN
    Toxicol Ind Health; 1986 Sep; 2(2):105-18. PubMed ID: 3787646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive myalgias and polyarthralgias in a patient with myoadenylate deaminase deficiency.
    Lally EV; Friedman JH; Kaplan SR
    Arthritis Rheum; 1985 Nov; 28(11):1298-302. PubMed ID: 4063004
    [No Abstract]   [Full Text] [Related]  

  • 7. Myoadenylate deaminase deficiency in children.
    Ashwal S; Peckham N
    Pediatr Neurol; 1985; 1(3):185-91. PubMed ID: 3916903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoadenylate deaminase deficiency.
    Goebel HH; Bardosi A; Conrad B; Kuhlendahl HD; DiMauro S; Rumpf KW
    Klin Wochenschr; 1986 Apr; 64(7):342-7. PubMed ID: 3713108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial myoadenylate deaminase deficiency and exertional myalgia.
    Kelemen J; Rice DR; Bradley WG; Munsat TL; DiMauro S; Hogan EL
    Neurology; 1982 Aug; 32(8):857-63. PubMed ID: 7201581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia.
    Ginz HF; Girard T; Censier K; Urwyler A
    Eur J Anaesthesiol; 2004 Feb; 21(2):151-7. PubMed ID: 14977348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myoadenylate deaminase deficiency or not? Observations on two brothers with exercise-induced muscle pain.
    Hayes DJ; Summers BA; Morgan-Hughes JA
    J Neurol Sci; 1982 Jan; 53(1):125-36. PubMed ID: 7057200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic and immunologic evidence for a complete gene block in myoadenylate deaminase deficiency.
    Fishbein WN; Davis JI; Foellmer JW
    J Exp Pathol; 1983; 1(1):7-25. PubMed ID: 6086015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoadenylate deaminase deficiency.
    Goebel HH; Bardosi A
    Klin Wochenschr; 1987 Nov; 65(21):1023-33. PubMed ID: 3323644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoadenylate deaminase deficiency--muscle biopsy and muscle culture in a patient with gout.
    DiMauro S; Miranda AF; Hays AP; Franck WA; Hoffman GS; Schoenfeldt RS; Singh N
    J Neurol Sci; 1980 Aug; 47(2):191-202. PubMed ID: 7411167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No relationship between fiber type and halothane contracture test results in malignant hyperthermia.
    Heiman-Patterson T; Fletcher JE; Rosenberg H; Tahmoush AJ
    Anesthesiology; 1987 Jul; 67(1):82-4. PubMed ID: 2440353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency.
    Sabina RL; Swain JL; Patten BM; Ashizawa T; O'Brien WE; Holmes EW
    J Clin Invest; 1980 Dec; 66(6):1419-23. PubMed ID: 7440723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
    Sabina RL; Swain JL; Olanow CW; Bradley WG; Fishbein WN; DiMauro S; Holmes EW
    J Clin Invest; 1984 Mar; 73(3):720-30. PubMed ID: 6707201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tests of contracture and sensitivity to malignant hyperthermia in 27 patients].
    Krivosic-Horber R; Adnet P; Krivosic I; Theunynck D; Guévart E; Adamantidis M
    Ann Fr Anesth Reanim; 1988; 7(2):132-8. PubMed ID: 3364812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenylate kinase deficiency and malignant hyperthermia.
    Cerri CG; Willner JH; Britt BA; Wood DS
    Hum Genet; 1981; 57(3):325-6. PubMed ID: 6265342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoadenylate deaminase deficiency in twins with recessive olivopontocerebellar atrophy.
    Uziel G; Cornelio F; Gellera C; Perego C; Rimoldi M; DiDonato S
    Ital J Neurol Sci; 1986 Feb; 7(1):107-12. PubMed ID: 3957624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.